MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in KYMR — Kymera Therapeutics, Inc.

CIK 1705339 CAUSEWAY BAY, K3

Position in KYMR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,715,918

+$1,525,995 QoQ

Shares Held

41,126

+7.4% QoQ

Ownership

0.049%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#93

of 273 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $436,102,859 across 286 Biotechnology names. KYMR ranks #16 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	150,692	$74,853,236
2	REGN	Regeneron Pharmaceuticals, Inc.	59,595	$37,159,864
3	ALNY	Alnylam Pharmaceuticals, Inc.	63,265	$19,044,662
4	RPRX	Royalty Pharma plc	259,390	$14,543,997
5	INCY	Incyte Corp	83,084	$9,418,401
6	PRAX	Praxis Precision Medicines, Inc.	27,185	$9,101,265
7	MRNA	Moderna, Inc.	106,564	$7,462,676
8	CRSP	CRISPR Therapeutics AG	122,658	$6,689,766

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,715,918	41,126	+7.4%	Shares	Defined	2026-08-14
2026-03-31	$3,189,923	38,299	-6.1%	Shares	Defined	2026-05-15
2025-12-31	$3,172,858	40,777	+51.5%	Shares	Defined	2026-02-17
2025-09-30	$1,523,558	26,918	-2.5%	Shares	Defined	2025-11-14
2025-06-30	$1,204,944	27,611	-10.3%	Shares	Defined	2025-08-14
2025-03-31	$842,804	30,793	+6.3%	Shares	Defined	2025-05-15
2024-12-31	$1,165,060	28,960	+7.5%	Shares	Defined	2025-02-14
2024-09-30	$1,275,495	26,949	+9.7%	Shares	Defined	2024-11-14
2024-06-30	$733,414	24,570	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.